These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 34431250)

  • 21. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.
    Han K; Kim JH; Ko GY; Gwon DI; Sung KB
    World J Gastroenterol; 2016 Jan; 22(1):407-16. PubMed ID: 26755886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immuno-oncology : No longer a need for interventional radiology?].
    Saborowski A; Vogel A
    Radiologe; 2020 Aug; 60(8):687-692. PubMed ID: 32671491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Intermediate-Stage Hepatocellular Carcinoma: Systemic Versus Locoregional Therapy.
    Patel M; Pillai A
    Surg Oncol Clin N Am; 2024 Jan; 33(1):159-172. PubMed ID: 37945141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multimodal treatment of hepatocellular carcinoma].
    Kirstein MM; Wirth TC
    Internist (Berl); 2020 Feb; 61(2):164-169. PubMed ID: 31919533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current locoregional therapies and treatment strategies in hepatocellular carcinoma.
    Cardarelli-Leite L; Hadjivassiliou A; Klass D; Chung J; Ho SGF; Lim HJ; Kim PTW; Mujoomdar A; Liu DM
    Curr Oncol; 2020 Nov; 27(Suppl 3):S144-S151. PubMed ID: 33343208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined interventional therapies of hepatocellular carcinoma.
    Qian J; Feng GS; Vogl T
    World J Gastroenterol; 2003 Sep; 9(9):1885-91. PubMed ID: 12970869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New concepts in embolotherapy of HCC.
    Pesapane F; Nezami N; Patella F; Geschwind JF
    Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transarterial ablative therapy of hepatocellular carcinoma].
    Mahnken AH
    Radiologe; 2014 Jul; 54(7):685-93. PubMed ID: 25047524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of interventional radiology in managing pediatric liver tumors : Part 1: Endovascular interventions.
    Lungren MP; Towbin AJ; Roebuck DJ; Monroe EJ; Gill AE; Thakor A; Towbin RB; Cahill AM; Matthew Hawkins C
    Pediatr Radiol; 2018 Apr; 48(4):555-564. PubMed ID: 29362840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
    Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
    Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage locoregional therapies for recurrent hepatocellular carcinoma.
    Criss CR; Makary MS
    World J Gastroenterol; 2023 Jan; 29(3):413-424. PubMed ID: 36688022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities.
    da Fonseca LG; Araujo RLC
    World J Gastroenterol; 2022 Jul; 28(28):3573-3585. PubMed ID: 36161045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.
    Bargellini I; Florio F; Golfieri R; Grosso M; Lauretti DL; Cioni R
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):438-44. PubMed ID: 23719667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New progress of non-surgical treatments for hepatocellular carcinoma.
    Cheng JW; Lv Y
    Med Oncol; 2013 Mar; 30(1):381. PubMed ID: 23292867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HCC: Transarterial Therapies-What the Interventional Radiologist Can Offer.
    Vogl TJ; Gruber-Rouh T
    Dig Dis Sci; 2019 Apr; 64(4):959-967. PubMed ID: 30835030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.
    Memon K; Kulik L; Lewandowski RJ; Gupta R; Ryu RK; Miller FH; Vouche M; Atassi R; Ganger D; Mulcahy MF; Salem R
    J Vasc Interv Radiol; 2013 Aug; 24(8):1189-1197.e2. PubMed ID: 23474327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study.
    Huang YH; Park BV; Chen YF; Gaba RC; Guzman G; Lokken RP
    J Vasc Interv Radiol; 2019 Sep; 30(9):1317-1324. PubMed ID: 31375450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.
    Young S; Golzarian J
    AJR Am J Roentgenol; 2020 Jul; 215(1):223-234. PubMed ID: 32255691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.